Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
5.62%
↑ 145% above average
Average (26q)
-12.45%
Historical baseline
Range
High:86.70%
Low:-341.90%
Volatility
-3441.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 5.62% |
| Q2 2025 | 22.61% |
| Q1 2025 | 41.03% |
| Q4 2024 | 48.00% |
| Q3 2024 | -7.14% |
| Q2 2024 | -1.45% |
| Q1 2024 | 4.17% |
| Q4 2023 | 17.24% |
| Q3 2023 | -11.54% |
| Q2 2023 | -14.71% |
| Q1 2023 | 0.00% |
| Q4 2022 | -58.14% |
| Q3 2022 | 33.85% |
| Q2 2022 | -32.65% |
| Q1 2022 | -11.36% |
| Q4 2021 | -4.76% |
| Q3 2021 | -10.53% |
| Q2 2021 | -52.00% |
| Q1 2021 | -4.17% |
| Q4 2020 | 11.11% |
| Q3 2020 | -341.90% |
| Q2 2020 | -10.49% |
| Q1 2020 | -84.95% |
| Q4 2019 | 39.23% |
| Q3 2019 | 86.70% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |